ScholarIQanswers from OpenAlex & ORCID
Wenyan Zhong
ResearcherPublications, citations & collaboration network
Wenyan Zhong is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Wenyan Zhong have?
ScholarIQindexed works
Wenyan Zhong has 89 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Wenyan Zhong have?
ScholarIQcitation count
Wenyan Zhong has 23,344 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Wenyan Zhong?
ScholarIQh-index
Wenyan Zhong has an h-index of 22 in OpenAlex.
What is the i10-index of Wenyan Zhong?
ScholarIQi10-index
Wenyan Zhong has an i10-index of 29 in OpenAlex.
What is the ORCID of Wenyan Zhong?
ScholarIQorcid
The ORCID for Wenyan Zhong is on the source record.
What is the OpenAlex record for Wenyan Zhong?
ScholarIQopenalex
The OpenAlex for Wenyan Zhong is on the source record.
What are the most-cited papers on Wenyan Zhong?
ScholarIQmost cited works
Comparative Genomics of the Eukaryotes
Gerald M. Rubin, Mark Yandell, Jennifer R. Wortman, George L. Gabor, Miklós, Catherine R. Nelson, Iswar K. Hariharan, Mark Fortini, Peter W. Li, Rolf Apweiler, Wolfgang Fleischmann, J. Michael Cherry, Steven Henikoff, Marian Skupski, Sima Misra, Michael Ashburner, Ewan Birney, Mark S. Boguski, Thomas Brody, Peter Brokstein, S Celniker, Stephen A. Chervitz, David Coates, Anibal Cravchik, Andrei Gabrielian, Richard F. Galle, William M Gelbart, Reed George, Lawrence S.B. Goldstein, Fangcheng Gong, Ping Guan, Nomi L. Harris, Bruce A. Hay, Roger A. Hoskins, Jiayin Li, Zhenya Li, Richard O. Hynes, Steven J.M. Jones, Peter Kuehl, Bruno Lemaître, J. Troy Littleton, Deborah K. Morrison, Chris Mungall, Patrick H. O’Farrell, Oxana K. Pickeral, Chris Shue, Leslie B. Vosshall, Jiong Zhang, Qi Zhao, Xiangqun Zheng-Bradley, Fei Zhong, Wenyan Zhong, Richard A. Gibbs, J. Craig Venter, Mark D. Adams, Suzanna Lewis
A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome
Richard Mural, Mark D. Adams, Eugene W. Myers, Hamilton O. Smith, George L. Gabor Miklos, Ron Wides, Aaron L. Halpern, Peter W. Li, Granger G. Sutton, Joe Nadeau, Steven L. Salzberg, Robert A. Holt, Chinnappa D. Kodira, Fu Lu, Lin Chen, Zuoming Deng, Carlos Evangelista, Weiniu Gan, Thomas J. Heiman, Jiayin Li, Zhenya Li, Gennady V. Merkulov, Natalia V. Milshina, Ashwinikumar K. Naik, Rong Qi, Bixiong Chris Shue, Aihui Wang, Jian Wang, Xin Wang, Xianghe Yan, Jane J. Ye, Shibu Yooseph, Qi Zhao, Liansheng Zheng, Shiaoping C. Zhu, Kendra Biddick, Randall Bolanos, Arthur L. Delcher, Ian Dew, Daniel Fasulo, Michael J. Flanigan, Daniel H. Huson, Saul Kravitz, Jason Miller, Clark Mobarry, Knut Reinert, Karin Remington, Qing Zhang, Xiangqun Zheng-Bradley, Deborah Nusskern, Zhongwu Lai, Yiding Lei, Wenyan Zhong, Alison Yao, Ping Guan, Rui‐Ru Ji, Zhiping Gu, Zhenyuan Wang, Fei Zhong, Chunlin Xiao, Chia-Chien Chiang, Mark Yandell, Jennifer R. Wortman, Peter G. Amanatides, Suzanne L. Hladun, Eric C. Pratts, Jeffery E. Johnson, Kristina Dodson, Kerry J. Woodford, Cheryl Evans, Barry Gropman, Douglas B. Rusch, Eli Venter, Mei Wang, Thomas J. Smith, Jarrett Houck, Donald E. Tompkins, Charles A. Haynes, Debbie Jacob, Soo Chin, David R. Allen, Carl Dahlke, Robert D. Sanders, Kelvin Li, Xiangjun Liu, Alexander A. Levitsky, William H. Majoros, Quan Chen, Ashley C. Xia, John Lopez, Michael Donnelly, Matthew Newman, Anna Glodek, Cheryl Kraft, Marc Nodell, Feroze Ali, Hui-Jin An, Danita Baldwin-Pitts, Karen Beeson, Shuang Cai
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial
Shukui Qin, Zhendong Chen, Weijia Fang, Zhenggang Ren, Ruocai Xu, Baek‐Yeol Ryoo, Zhiqiang Meng, Yuxian Bai, Xiaoming Chen, Xiufeng Liu, Juxiang Xiao, Gwo Fuang Ho, Yimin Mao, Xin Wang, Jieer Ying, Jianfeng Li, Wenyan Zhong, Yu Zhou, Abby B. Siegel, Chunyi Hao